Shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) have received an average rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $105.3333.
USPH has been the subject of several research reports. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Barrington Research reaffirmed an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a report on Monday, January 5th. JPMorgan Chase & Co. dropped their price objective on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, November 24th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st.
Read Our Latest Analysis on USPH
Hedge Funds Weigh In On U.S. Physical Therapy
U.S. Physical Therapy Stock Performance
Shares of USPH stock opened at $86.99 on Monday. U.S. Physical Therapy has a 52 week low of $62.77 and a 52 week high of $93.50. The firm has a 50 day moving average of $82.50 and a two-hundred day moving average of $82.10. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $1.32 billion, a PE ratio of 36.55, a P/E/G ratio of 3.59 and a beta of 1.30.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Further Reading
- Five stocks we like better than U.S. Physical Therapy
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- America’s 1776 happening again
- Trump & Musk’s Secret Bet on Silver — Exposed
- URGENT: Sell this stock immediately
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
